Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Randomized, Controlled Trial of Rectal Indomethacin in the Prevention of Post-ERCP Pancreatitis in High Risk Patients.

NCT00820612 is registered in ClinicalTrials.gov with University of Michigan as lead sponsor.

NCT NCT00820612
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00820612 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Randomized, Controlled Trial of Rectal Indomethacin in the Prevention of Post-ERCP Pancreatitis in High Risk Patients.
Lead sponsor
University of Michigan
Phase
Phase 4
Overall status
Terminated
Start date
January 31, 2009
Completion date
July 31, 2011
Enrollment
602 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

post-ercp pancreatitis